Tamoxifen and TRAIL synergistically induce apoptosis in breast cancer cells

Oncogene

Volumn 27, Issue 10, 2008, Pages 1472-1477

  Lagadec, C ^a   Adriaenssens, E ^a   Toillon, R A ^a   Chopin, V ^a   Romon, R ^a   Van Coppenolle, F ^a   Hondermarck, H ^a   Le Bourhis, X ^a  

^a INSERM   (France)

Author keywords

Apoptosis; Breast cancer; Tamoxifen; TRAIL; Tumor xenograft

Indexed keywords

CASPASE 8; CASPASE 9; ESTROGEN RECEPTOR ALPHA; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; PROTEIN; PROTEIN BAX; PROTEIN BID; PROTEIN BNIP3; PROTEIN TBID; SMALL INTERFERING RNA; TAMOXIFEN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; GROWTH INHIBITORS; HUMANS; TAMOXIFEN; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 39849100669     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210749     Document Type: Article

References (17)